Correlative results from NCI CTEP/ETCTN 10330: A phase 2 study of belinostat with SGI-110 (guadecitabine) or ASTX727 (decitabine/cedazuridine) for advanced conventional chondrosarcoma (cCS) Meeting Abstract
| Authors: | Lacuna, K. P.; Ingham, M.; Chen, L.; Das, B.; Lee, S. M.; Ge, L.; Druta, M.; Conley, A. P.; Keohan, M. L.; Agulnik, M.; Burgess, M. A.; Chalmers, A. W.; D'Amato, G. Z.; Powers, B.; Seetharam, M.; Siontis, B. L.; Pelosof, L. C.; Van Tine, B. A.; Schwartz, G. K.; Weiss, M. C. |
| Abstract Title: | Correlative results from NCI CTEP/ETCTN 10330: A phase 2 study of belinostat with SGI-110 (guadecitabine) or ASTX727 (decitabine/cedazuridine) for advanced conventional chondrosarcoma (cCS) |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557402684 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.11526 |
| Notes: | Meeting Abstract: 11526 -- Source: Wos |
